| VFFSX | VIIIX | VFFSX / VIIIX | |
| Total Expense Ratio | 0.01 | 0.02 | 50% |
| Annual Report Gross Expense Ratio | 0.01 | 0.02 | 50% |
| Fund Existence | 10 years | 29 years | - |
| Gain YTD | 11.765 | 10.950 | 107% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000000 | 100000000 | 5,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.69T | 348B | 485% |
| Annual Yield % from dividends | 1.08 | 1.08 | 101% |
| Returns for 1 year | 19.51 | 17.67 | 110% |
| Returns for 3 years | 73.91 | 66.64 | 111% |
| Returns for 5 years | 72.27 | 57.80 | 125% |
| Returns for 10 years | 250.40 | 206.88 | 121% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FITFX | 19.59 | 0.03 | +0.15% |
| Fidelity Flex International Index | |||
| IRCZX | 15.82 | -0.02 | -0.13% |
| AB International Small Cap Z | |||
| BLNAX | 14.97 | -0.08 | -0.53% |
| Meeder Balanced Adviser | |||
| CSPAX | 81.83 | -0.68 | -0.82% |
| American Funds SMALLCAP World 529-A | |||
| BIPIX | 100.07 | -5.78 | -5.46% |
| ProFunds Biotechnology UltraSector Inv | |||